APIDRA 100 U/ml Price in UAE

Overview

Welcome to Dwaey, specifically on APIDRA 100 U/ml page.
This medicine contains an important and useful components, as it consists of
Insulin - Glulisineis available in the market in concentration

Name

Insulin Glulisine

Precaution

Renal or hepatic impairment. Regular monitoring of blood glucose and HbA1c. Rotate Inj sites to reduce lipodystrophy . Pregnancy, lactation. Lactation: Considered safe during breastfeeding

Indication

Diabetes mellitus

Contra indication

Hypoglycaemia.Hypersensitivity to any of the components.

Side Effect

Hypoglycaemia, Inj site reactions, lipodystrophy, local and systemic hypersensitivity reactions.

Pregnancy Category ID

Mode of Action

Insulin glulisine is a rapid acting human insulin analog produced by recombinant DNA technology using a non-pathogenic laboratory strain of Escherichia coli (K12). Insulin glulisine and insulin human are equipotent on a unit-for-unit basis. Insulin glulisine has a more rapid onset and shorter duration of action compared with insulin human after subcutaneous admin.

Interaction

Possible absence of hypoglycaemic warning symptoms with beta-blockers. Decreased hypoglycaemic effect with corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, phenothiazine derivatives, somatropin, sympathomimetic agents, thyroid hormones, oestrogens, progestins (e.g. in oral contraceptives), protease inhibitors and atypical antipsychotics (e.g. olanzapine and clozapine). Increased hypoglycaemic effect with oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, propoxyphene, salicylates and sulfonamide antibiotics. Decreased insulin resistance with octreotide and lanreotide. Increased risk of wt gain and peripheral oedema with pioglitazone, rosiglitazone. Decreased effect of sermorelin.